GT
IRMD icon

Glenmede Trust’s iRadimed IRMD Stock Holding History

Glenmede Trust’s Portfolio IRMD Stock Details IRMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q1 		– Sell
-450
Closed -$4K – 2710
2016
Q4 		$4K Sell
450
-375
-45% -$4.04K ﹤0.01% 2266
2016
Q3 		$14K Buy
825
+450
+120% +$8.33K ﹤0.01% 2048
2016
Q2 		$8K Hold
375
– – ﹤0.01% 2150
2016
Q1 		$7K Buy
375
+150
+67% +$2.87K ﹤0.01% 2131
2015
Q4 		$6K Buy
+225
New +$6.36K ﹤0.01% 2212

Other funds holding IRMD

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
MIP
Mondrian Investment Partners London, United Kingdom $6.69B AUM
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
GIP
Granite Investment Partners El Segundo, California $1.63B AUM 38.09% 1-Year Est. Return
MERSOM
Municipal Employees' Retirement System of Michigan Lansing, Michigan $8.81B AUM 10.88% 1-Year Est. Return
GC
Globeflex Capital San Diego, California $661M AUM 50.59% 1-Year Est. Return
SIM
Spark Investment Management New York $41.6M AUM 80.97% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
MC
Menta Capital San Francisco, California $236M AUM 6.6% 1-Year Est. Return

Glenmede Trust's IRMD Position: Q1 2017 in Review

Glenmede Trust sold out of iRadimed (IRMD) in Q1 2017, closing a stake of 450 shares — an estimated $4K sold.

Glenmede Trust first reported a position in IRMD in Q4 2015 and held it in 5 quarters. The position peaked at $14K in Q3 2016. 46 funds tracked by Wall St. Rank hold IRMD as of Q1 2017.

  • Glenmede Trust reported no remaining iRadimed position as of Q1 2017 after selling out during the quarter.
  • Glenmede Trust sold 450 iRadimed shares in Q1 2017, an estimated $4K.
  • Glenmede Trust first reported a position in iRadimed in Q4 2015 and held it in 5 quarters.
  • Glenmede Trust's iRadimed position peaked at $14K in Q3 2016.
  • 46 funds tracked by Wall St. Rank held iRadimed as of Q1 2017.

Based on Glenmede Trust's 13F filing for Q1 2017, filed 15 May 2017.